Literature DB >> 7042141

Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease.

J Sancho, J Egido, M Sánchez-Crespo, R Blasco.   

Abstract

The purpose of this study was to characterize circulating IgA and the IgA deposited in the glomeruli of patients with alcoholic liver disease. In the 6 patients studied there was an increased proportion in monomeric IgA (3.5 fold) and IgA between 9-13S (8.94 fold), 13-17S (4.49 fold) and 17-21S (1.63 fold) fractions on 5-40% sucrose density gradient ultracentrifugation at physiological pH. All fraction between 9.12S decreased at acid pH, however a 3.28 fold increase in fractions where polymeric IgA is expected to appear. IgG eluted at acid pH from autopsy kidney was studied by the same procedures. At pH 7.4 about 55% of that IgA have a molecular weight comprised between 9-12S, decreasing to around 25% at acid pH. The existence of true polymeric IgA in serum and kidney was based on the capacity of high molecular weight IgA to bind human secretory component. The amount of immune complexes with monomeric IgA were higher than those with polymeric IgA in serum as well as in kidney. However, the percentage of heavy IgA (probably polymeric IgA) in kidney were, in each patient, higher than those observed in serum. Our results show the presence of high amounts of monomeric and polymeric IgA, both partially as immune complexes, in serum and kidneys of patients with alcoholic liver disease and IgA glomerulonephritis. Furthermore, our data suggest a role for human liver in the clearance of serum IgA such as has been demonstrated in the some animal species, especially in rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042141      PMCID: PMC1536534     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Rat bile as a convenient source of secretory IgA and free secretory component.

Authors:  I Lemaître-Coelho; G D Jackson; J P Vaerman
Journal:  Eur J Immunol       Date:  1977-08       Impact factor: 5.532

2.  [Role of monomeric and dimeric immunoglobulin A in the hypergammaglobulinemia of alcoholic cirrhosis].

Authors:  F André; C André
Journal:  Biol Gastroenterol (Paris)       Date:  1976 Apr-May

3.  Serum immunoglobulin A changes in alcoholic patients.

Authors:  H Iturriaga; T Pereda; A Estévez; G Ugarte
Journal:  Ann Clin Res       Date:  1977-02

4.  Characteristics of SC-Ig complexes formed in vitro.

Authors:  P Brandtzaeg
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

5.  Isolation of human secretory component by affinity chromatography on IgM-sepharose.

Authors:  B J Underdown; J DeRose; K Koczekan; D Socken; J Weicker
Journal:  Immunochemistry       Date:  1977-02

6.  Studies on J chain and binding site for secretory component in circulating human B cells. II. The cytoplasm.

Authors:  P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

7.  Serum immunoglobulins and organ non-specific antibodies in diseases of the liver.

Authors:  G Husby; S Skrede; J P Blomhoff; C D Jacobsen; K Berg; E Gjone
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

8.  Enzymatic iodination of polypeptides with 125I to high specific activity.

Authors:  J I Thorell; B G Johansson
Journal:  Biochim Biophys Acta       Date:  1971-12-28

9.  Immune complex type glomerulonephritis in cirrhosis of the liver.

Authors:  P Callard; G Feldmann; D Prandi; M F Belair; C Mandet; Y Weiss; P Druet; J P Benhamou; J Bariety
Journal:  Am J Pathol       Date:  1975-08       Impact factor: 4.307

10.  Association of overt glomerulonephritis and liver disease: a study of 34 patients.

Authors:  D Nochy; P Callard; B Bellon; J Bariety; P Druet
Journal:  Clin Nephrol       Date:  1976-10       Impact factor: 0.975

View more
  24 in total

1.  Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy.

Authors:  S Suzuki; S Fujieda; H Sunaga; H Sugimoto; C Yamamoto; H Kimura; T Abo; F Gejyo
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 2.  Renal impairment in cirrhosis unrelated to hepatorenal syndrome.

Authors:  Gavin Low; Graeme Jm Alexander; David J Lomas
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04-15

3.  Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.

Authors:  J González-Cabrero; J Egido; A Barat; E González
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

4.  Molecular forms of IgA produced by various lymphoid tissues--analysis using high speed liquid chromatography.

Authors:  M Arashi; Y Akahonai; M Mori; T Hirane; A Yachi
Journal:  Gastroenterol Jpn       Date:  1987-12

5.  IgA mesangial deposits in C3H/HeJ mice after oral immunization with ferritin or bovine serum albumin.

Authors:  C Genin; B Laurent; J C Sabatier; S Colon; F C Berthoux
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

6.  [Alcohol and IgA in the kidney].

Authors:  H Köhler
Journal:  Klin Wochenschr       Date:  1985-09-16

7.  Circulating IgA immune complexes and skin IgA deposits in liver disease. Relation to liver histopathology.

Authors:  A van de Wiel; R M Valentijn; H J Schuurman; M R Daha; R J Hené; L Kater
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

8.  Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates.

Authors:  J Sancho; E González; F Rivera; J F Escanero; J Egido
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

9.  [Kidney involvement in liver diseases: morphology].

Authors:  G Syré
Journal:  Klin Wochenschr       Date:  1983-10-17

10.  IgA nephritis in a child with human immunodeficiency virus: a unique form of human immunodeficiency virus-associated nephropathy?

Authors:  M J Schoeneman; V Ghali; K Lieberman; L Reisman
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.